|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
We have designed a computerized system providing closed-loop control of the level of pressure support ventilation (PSV). The system sets itself at the lowest level of PSV that maintains respiratory rate (RR), tidal volume (VT), and end-tidal CO2 pressure (PETCO2) within predetermined ranges defining acceptable ventilation (i.e., 12 < RR < 28 cycles/min, VT > 300 ml [> 250 if weight < 55 kg], and PETCO2 < 55 mm Hg [< 65 mm Hg if chronic CO2 retention]). Ten patients received computer-controlled (automatic) PSV and physician-controlled (standard) PSV, in random order, during 24 h for each mode. An estimation of occlusion pressure (P0.1) was recorded continuously. The average time spent with acceptable ventilation as previously defined was 66 ± 24% of the total ventilation time with standard PSV versus 93 ± 8% with automatic PSV (p < 0.05), whereas the level of PSV was similar during the two periods (17 ± 4 cm H2O versus 19 ± 6 cm H2O). The time spent with an estimated P0.1 above 4 cm H2O was 34 ± 35% of the standard PSV time versus only 11 ± 17% of the automatic PSV time (p < 0.01). Automatic PSV increased the time spent within desired ventilation parameter ranges and apparently reduced periods of excessive workload.
| |
INTRODUCTION |
|---|
|
|
|---|
Pressure support ventilation (PSV) is a mode of partial respiratory support that is widely used, especially during gradual weaning from mechanical ventilation (1). Because PSV is not a volume-controled mode, any change in respiratory mechanics modifies the delivered volume. Also, changes in respiratory demand may require adjustment of the PSV level over time as the patient's respiratory function returns to normal. PSV must be individually adjusted to the level that keeps spontaneous respiratory efforts within a reasonable range (3). Because PSV adjustment is often based on objective data, automatic control of ventilator settings via a computerized system is conceivable. The expected advantages of computerized PSV control include continuous delivery of optimized mechanical assistance and rationalization of the weaning process based on predefined guidelines. We have previously described a knowledge-based, closed-loop system that uses simple indexes to evaluate the patient's needs and to adjust the level of mechanical assistance accordingly (5, 6). We have shown that this system is useful during the weaning period for determining the optimal time for extubation and can advantageously replace the standard battery of preweaning tests and the 2-h T-piece trial (7).
The objective of the present clinical study was to test, during ventilation and before weaning initiation, the effectiveness of our closed-loop system in ensuring adequate ventilation and preventing respiratory failure. To assess the potential benefits provided by automatic PSV level control, we compared our computerized closed-loop PSV system (automatic PSV) with physician-controlled PSV (standard PSV). In particular, we specifically assessed the efficacy of automatic PSV in preventing periods with a high breathing workload. We used an estimation of occlusion pressure (P0.1) as a surrogate for work of breathing (8, 9).
| |
METHODS |
|---|
|
|
|---|
Patients
Ten patients were selected for the study. All patients received PSV after recovering from acute respiratory failure. The main patient characteristics are shown in Table 1. Inclusion criteria were as follows: a high likelihood that mechanical ventilation would be required for the next 48 h; mechanical ventilation delivered by PSV alone at a level of 10 cm H2O or more; hemodynamic stability; and informed consent obtained from the patient or next-of-kin.
|
Material
All patients were ventilated using a Veolar ventilator (Hamilton Medical, Bonaduz, Switzerland) set to PSV mode. For computer-controlled PSV, a computer connected via two RS-232 digital outputs to the Veolar controlled the ventilator settings and received information about the patient, assessing respiratory rate (RR), tidal volume (VT), and the PSV level through the ventilator. Another serial port connected to a mainstream gas monitor (Novametrix 1260; Wallingford, CT) assessed end-tidal PCO2 (PETCO2). All data were sampled every 10 s and averaged over 2 min. Evaluation of the current respiratory status of the patient was based on these parameters as they changed over time. The functionalities of the system were developed based on clinician's knowledge modeled using forward-chaining production rules. Details on the medical knowledge representation can be found in a previous report (6). Briefly, the working principle is based on two goals: to keep ventilation within an "acceptable range" by periodically adjusting the PSV level; and to use the lowest PSV level providing acceptable ventilation defined as a RR between 12 and 28 breaths/min, VT above 250 ml (300 ml in patients weighing > 50 kg), and PETCO2 below 55 mm Hg (65 mm Hg in patients with chronic CO2 retention, due for instance to chronic obstructive pulmonary disease [COPD]). When the RR is 28 to 35 breaths/min with acceptable values for both PETCO2 and VT (intermediate RR), the PSV level is increased by 2 cm H2O; the increase is by 4 cm H2O when the RR exceeds 35 breaths/ min (high RR). PSV is decreased by 4 cm H2O when the RR is 12 breaths/min or less (low RR). When VT or PETCO2 are outside the defined limits (low VT or high PETCO2), PSV is increased by 2 cm H2O. If an apnea lasting longer than 30 s occurs, the ventilatory mode is automatically switched to assist-control as a safety feature.
PSV level modifications take into account the patient's breathing pattern history, particularly the presence of transient instabilities. For example, a PSV level below 15 cm H2O is decreased by 2 cm H2O if ventilation has been acceptable for the last 30 min, and a PSV level higher than 15 cm H2O is decreased by 4 cm H2O if ventilation has been acceptable for the last 60 min. In addition, to avoid unnecessary PSV modifications, the system tolerates transient instabilities for 2 min or 4 min according to whether PSV is lower or higher than 15 cm H2O, respectively. In the event of tachypnea or inadequate ventilation for 2 min, a PSV level lower than 15 cm H2O is increased by 2 cm H2O, whereas a PSV level higher than 15 cm H2O is increased by 4 cm H2O. Patient status is evaluated at 2-min intervals. After a 4 cm H2O change in PSV, the next patient status evaluation occurs after a 4-min observation period. The computer screen displays a message if ventilation is unacceptable at three consecutive evaluations (12 min) despite PSV level changes; this did not occur during the present study.
When the patient has tolerated a low level of PSV (9 cm H2O, or 5 cm H2O if the patient is tracheotomized) for 2 h, a message suggesting ventilator disconnection is displayed on the computer screen. Again, transient instabilities are tolerated. The specific efficacy of this feature of the system has been assessed previously (7).
All ventilator alarms remain enabled during automatic PSV. Before connection of the patient to the system, information on the patient (e.g., name, weight, intubation or tracheotomy, and presence of COPD) must be entered into the computer. Apart from this, the computer-controlled mode requires no external intervention. Because the system can differentiate apnea from disconnection, it does not interfere with usual patient care procedures, such as endotracheal suctioning.
In the standard (physician-controlled) PSV mode used in the present study, the same computer was connected to the ventilator but was used only for recording physiological parameters and ventilator settings, which could be modified at any time by the physician in charge. The physicians were given as little information as possible about the study to ensure that management would be performed according to standard practice in our unit. In particular, they were not aware of the details of the algorithm used by the computer-controlled system. A message displayed on the computer screen indicated whether the automatic control system was active or not. For safety reasons, when the system was active it could be inactivated at any time by the physician in charge, who could then control the ventilator manually. When the computerized system was not active, the physician in charge could modify the PSV at his or her discretion. Thus, the physicians were relatively naive about the system, and it is unlikely that the presence of the computer changed their behavior.
In addition to the above-mentioned parameters, P0.1 was recorded continuously to provide an indirect assessment of patient's effort (8, 9). P0.1, defined as the airway pressure (Paw) generated 100 ms after the onset of an occluded inspiration, has been used previously as an estimate of the neuromuscular drive of respiration (10). Recently developed ventilators or monitors are capable of measuring P0.1, usually during an on-demand end-expiratory pause. Although this measurement method is reliable, it is not convenient for on-line monitoring. We elected to use a direct method applicable in patients receiving PSV. With a closed triggering system, a short pause occurs during the patient's effort to trigger the ventilator. P0.1 can be estimated from the negative Paw generated by the patient's inspiratory effort during this pause (11, 12). Because the pause is often shorter than 100 ms, we obtained P0.1 from an extrapolation of Paw measured during the 50-ms period preceding the opening of the ventilator demand valve. In our study, P0.1 (called the "estimated P0.1") was measured using the computerized B-analyzer system (Hamilton). This system uses pressure and flow analog signals measured by sensors attached to the ventilator as inputs, and a PCO2 analog signal measured directly by the mainstream gas monitor. It calculates in real time the estimated P0.1 based on an algorithm that uses the flow and PCO2 signals to accurately determine the end of expiration. Six Paw values are used for linear regression, and the value at 100 ms is then determined by extrapolation. Similarly to the other study parameters, estimated P0.1 was sampled every 10 s and averaged over 2 min. Estimated P0.1 could not be recorded in one patient (Patient 9) for technical reasons. Estimated P0.1 was used as a surrogate for work of breathing (8, 9). We compared the time spent with high P0.1 values during each PSV mode. For this comparison, we defined "high P0.1" as an estimated P0.1 value greater than 4 cm H2O, as proposed by Conti and coworkers during PSV (13).
Protocol
The protocol was approved by our institutional review board. Each patient was consecutively ventilated for 24 h with the computer-controlled PSV mode (automatic PSV) and for 24 h with the physician-controlled PSV mode (standard PSV), in random order. In the standard PSV mode, the physician in charge modified the PSV level at his or her discretion. With both modes, the initial PSV level was set by the physician in charge.
Statistics
Wilcoxon's test for paired values was used to look for differences between the two PSV modes regarding study parameter values and the time spent with these parameters outside predefined ranges. p Values lower than 0.05 were considered significant.
| |
RESULTS |
|---|
|
|
|---|
All ten patients were ventilated using both PSV modes. Table 1 summarizes the patient characteristics. Mean total ventilation duration was 27 ± 17 d.
Mean durations of standard PSV and automatic PSV were 23 ± 3 h and 24 ± 4 h, respectively. Table 2 reports the mean values of the physiological parameters recorded with the two PSV modes, as well as the mean PSV level. No significant differences (all p values > 0.05) between the two PSV modes were found for any of the parameters shown in Table 2, and the mean PSV level was also similar with the two modes (17 ± 4 cm H2O and 19 ± 6 cm H2O for standard and automatic PSV, respectively).
|
In each individual patient, automatic PSV was associated with a longer time spent with acceptable ventilation and a shorter time spent in critical situations, as shown in Table 3. The mean time spent with acceptable RR, VT, and PETCO2 values, expressed as the percentage of total ventilation duration, was 66 ± 23% with standard PSV and 93 ± 8% with automatic PSV (p = 0.003). Three patients had a twofold or greater increase in the acceptable ventilation time during automatic PSV as compared with standard PSV. The number of PSV level changes was considerably higher with automatic PSV (56 ± 40) than with standard PSV (1 ± 2).
|
The time spent with unacceptable ventilation was broken down into periods of intermediate RR, low RR, high RR, low VT, and high PETCO2, according to the definitions in the METHODS and the last four represented the critical ventilation. The percentage of time spent with critical ventilation was 23% with standard PSV versus 3% with automatic PSV (p < 0.05). The unacceptable ventilation criterion met most often was a RR value outside the predefined range. The percentage of total ventilation spent with RR values between 28 and 35 was 12% with standard PSV versus 4% with automatic PSV (p = 0.02). Corresponding figures for the time spent with RR values greater than 35 breaths/min were 14% and 1% (p = 0.03). In each individual patient, automatic PSV was associated with less time spent with a high RR. These results are displayed in Figures 1 and 2.
|
|
The time spent with an estimated P0.1
4 cm H2O was
lower with automatic PSV than with standard PSV in eight of
the nine patients in whom it was measured. Mean percentage
of total ventilation time spent with an estimated P0.1
4 cm
H2O was 34 ± 35% with standard PSV versus 11 ± 17% with
automatic PSV (p < 0.01) (Table 4).
|
| |
DISCUSSION |
|---|
|
|
|---|
One of the main goals of mechanical ventilation is to reduce
the patient's effort or work of breathing. Our computer-controlled PSV system uses three parameters to automatically
control the level of assistance: RR, VT, and PETCO2. RR, which
seems to reflect how well the respiratory muscles adapt to the
workload (14), is the main parameter, while VT and PETCO2 are
used to improve safety. With standard PSV, most periods of
unacceptable ventilation were so classified based on an RR
value above the predefined range, consistent with the results
of our preliminary study (5). The computer-controlled system
responded to high RR values by increasing the PSV level. This
led to an increase in VT in Patients 5, 7, and 8. When ventilation remained acceptable for 30 or 60 min (depending on
whether PSV was below or above 15 cm H2O, respectively),
the system automatically decreased the level of PSV. The PSV
level was also decreased if hyperventilation occurred (RR
12 cycles/min). Because the system is designed to use the lowest level of PSV tolerated by the patient, our patients had
fewer critical situations while in automatic PSV mode. Mean
PSV level, however, was not significantly different between
automatic and standard PSV, because in some patients the
computer system increased PSV in response to episodes of tachypnea. However, specific additional automatic responses
could perhaps be introduced into the system to allow intermittent testing of whether a faster PSV level decrease would be
tolerated, the goal being to expedite weaning if possible.
The hypothesis that drove us to design our computer-controlled PSV system was that continuous PSV adjustment to the level ensuring acceptable ventilation may facilitate respiratory function recovery and weaning from mechanical ventilation (5, 7). High values of P0.1 and RR/VT have been shown to predict a high rate of weaning failure. In at least two of our patients (Patients 4 and 6), the work of breathing as evaluated based on the estimated P0.1 was substantially higher with standard PSV (4.5 cm H2O and 6.2 cm H2O, respectively) than with automatic PSV (2.9 cm H2O and 3.5 cm H2O, respectively). The rapid shallow breathing index in these two patients was 82 and 91 breaths/min/L with standard PSV versus 51 and 56 breaths/min/L with automatic PSV, respectively. Thus, in these two patients, automatic PSV reduced the overall breathing workload. As another example, with standard PSV, Patient 3 exhibited hyperventilation during 49% of the total ventilation time; the automatic system decreased the PSV level by 4 cm H2O as soon as hyperventilation was detected.
Overall, the time spent with high estimated P0.1 values was
significantly decreased with automatic PSV. The overall percentage of the total ventilation time spent with an estimated
P0.1 value higher than 4 cm H2O was substantially influenced
by the data from four patients (Patients 2, 4, 6, and 10), in
whom this percentage was > 50% with standard PSV. Had we
used
3 cm H2O as the P0.1 cutoff, the difference would not
have been significant (51 ± 43% with standard PSV versus
34 ± 41% with automatic PSV). However, reducing the cutoff
decreases the likelihood of finding a significant difference because the system is not designed to constantly reduce RR (and
presumably respiratory effort) as compared with standard PSV, but only to avoid unnecessary episodes of tachypnea and
high P0.1. It follows that differences are likely to be found only when out-of-range periods are considered. Both Alberti and
coworkers (8) and Mancebo and coworkers (9) reported close
correlations between P0.1 and the work of breathing. Thus, automatic PSV may have prevented prolonged periods of excessive work of breathing in our patients. This may have important implications for facilitating recovery from or avoiding
respiratory muscle fatigue (15). P0.1 could be used to improve
the PSV regulation loop. This parameter was introduced in a
servo-controlled system by Iotti and coworkers (16). Determining the optimal P0.1 value for an individual patient is still
empirical, however, and optimal threshold values for weaning
are still a matter of debate (17). Whether P0.1 could be used
as a second-line parameter for safety purposes needs to be determined.
The comparison between the days with and without automatic PSV allows one to understand why the system increased the PSV level and VT in some patients. It is interesting to see that the system succeeded in reaching the predefined goals. For instance, Figure 3 shows the time-course of the breathing pattern and PSV level in Patient 7. The RR/VT ratio in this patient was often around or above 100 (a very high value under PSV) without the system and, intuitively, the response of the automatic PSV system, which was to increase PSV, seems to have been very appropriate. In Patient 8, frequent episodes of transient tachypnea were avoided by automatic PSV. Patient 5 was very often at the upper limit for RR without automatic PSV, a fact that probably explains the higher PSV and VT levels with automatic than with standard PSV. In addition, very short periods of tachypnea (RR > 35 cycles/min) also resulted in PSV increases in this patient. One could argue that in such a patient the threshold for RR could have been raised slightly and the level of PSV decreased. Conceivably, the upper limit for RR could be determined case-by-case on the basis of the patient's history and clinical tolerance.
|
Mean PETCO2 was not different between standard and automatic PSV despite differences in the amount of time spent with rapid shallow breathing. We offer at least two explanations for the similar mean PETCO2 values with the two systems despite the difference in the amount of time spent with rapid shallow breathing. First, our system assesses the ventilatory status of the patient based primarily on RR. VT and PETCO2 serve mainly to improve safety. No target range is set for PETCO2, for which the only requirement is that the value be no higher than 55 mm Hg (65 in patients with COPD). Second, and more importantly, in a number of situations our system can help to avoid hypocapnia, for instance by decreasing the PSV level in response to an RR decrease below the acceptable range or by responding to an apnea with a high VT and a low PETCO2 value. In some patients, these responses of the system may result in a higher PETCO2 value compared with standard PSV.
The use of computers for automatic patient monitoring is
increasing in hospitals, especially in intensive care units. Few closed-loop systems for controlling ventilator settings have
been reported. Recent knowledge-based systems for patient
monitoring analyze the time-course of ventilation and advise
physicians about the best treatment response. They usually
deal with complex problems
such as the ventilation of neonates (21) or the design of general architectures for intensive
care monitoring (22, 23)
and explore sophisticated techniques
coming from the area of artificial intelligence. They do not act
on the ventilator and are difficult to evaluate clinically. Another avenue of research is the development of new ventilation modes based on algorithms that integrate physiological models to facilitate the weaning process. ARIS (24) and ALV (25), which are used in prototype ventilators, are good examples of the fruits of this approach. In ALV, automatic ventilation adjustments are based on measurements of the patient's
lung mechanics and series dead space, with the goals of achieving the lowest possible work of breathing and avoiding intrinsic positive end-expiratory pressure. ARIS is designed primarily to avoid hyperinflation and to gradually restore spontaneous
ventilation by allowing the patient to determine his or her RR,
VT, and inspiratory/expiratory ratio values compatible with an
optimal level of minute ventilation and a minimal VT determined by the physician. Because the introduction into the clinical environment of a new mode of ventilation is a time-consuming process, we chose to ventilate patients with PSV, a
mode widely used during weaning, and to use specific empirical knowledge with the goal of improving PSV use and of facilitating the weaning process. Based on our extensive clinical
experience and on data in the literature, we designed a computer-controlled PSV system to be used at the bedside. Our
work is similar to that by Strickland and Hasson (26, 27), who
developed a closed-loop system that modifies the setting of
synchronized intermittent mandatory ventilation and of PSV
for intervening breaths based on RR, VT, and pulse oximeter
oxygen saturation measurements. One important technical difference between their system and ours is that our system uses
specific temporal reasoning (6) to adjust PSV according to the
patient's ventilation history. Our system is designed to adjust
the PSV level whatever the stage of the weaning process. In
the present study, we investigated patients receiving PSV before the initiation of weaning. In contrast, Strickland and Hasson (27) studied only candidates for weaning.
Our main finding was that the automatic system was able to keep the patients within predefined ranges for physiological respiratory parameters. Our estimated P0.1 data suggest that this may provide benefits in terms of breathing workload and energy expenditure. We used the same predefined ranges in all our patients. It could be argued that individually tailored ranges may provide better results. Because the basic rules of knowledge-based systems are easy to grasp by users, individual tailoring of ranges is probably feasible. In the present study, the upper limit of the acceptable range for RR was 35 breaths/min but the system started to react when RR exceeded 28 breaths/min. These cutoffs could perhaps be increased in some situations, for instance in patients with chronic respiratory disorders associated with habitually high RRs.
The automatic PSV system used in this study was more effective in maintaining RR, VT, and PETCO2 within acceptable ranges than physician-controlled PSV. It would be of interest to conduct a large, randomized, controlled trial investigating the effects on weaning duration and outcomes of automatic versus standard PSV used early in the course of respiratory failure.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Prof. Laurent Brochard, Medical Intensive Care Unit, Hôpital Henri Mondor, 51, avenue de Maréchal de Lattre de Tassigny, 94 010 Creteil, France. E-mail: laurent.brochard{at}hmn.ap-hop-paris.fr
(Received in original form April 14, 1999 and in revised form September 21, 1999).
Acknowledgments: The authors thank Josef X. Brünner and Hamilton Medical AG for supplying the B-analyzer system and Florence Picot for typing the manuscript.
| |
References |
|---|
|
|
|---|
1. Brochard, L. 1994. Pressure support ventilation. In M. J. Tobin, editor. Principles and Practice of Mechanical Ventilation. McGraw-Hill, New York. 239-257.
2. Brochard, L., F. Pluskwa, and F. Lemaire. 1987. Improved efficacy of spontaneous breathing with inspiratory pressure support. Am. Rev. Respir. Dis. 32: 1110-1116 .
3. Brochard, L., A. Harf, H. Lorino, and F. Lemaire. 1989. Inspiratory pressure support prevents diaphragmatic fatigue during weaning from mechanical ventilation. Am. Rev. Respir. Dis. 139: 513-521 [Medline].
4.
MacIntyre, N. R..
1986.
Respiratory function during pressure support
ventilation.
Chest
89:
677-683
5. Dojat, M., L. Brochard, F. Lemaire, and A. Harf. 1992. A knowledge-based system for assisted ventilation of patients in intensive care units. Int. J. Clin. Monit. Comp. 9: 239-250 .
6. Dojat, M., F. Pachet, Z. Guessoum, D. Touchard, A. Harf, and L. Brochard. 1997. NeoGanesh: a working system for the automated control of assisted ventilation in ICUs. Artif. Intell. Med. 11: 97-117 [Medline].
7. Dojat, M., A. Harf, D. Touchard, M. Laforest, F. Lemaire, and L. Brochard. 1995. Evaluation of a knowledge-based system providing ventilatory management and decision for extubation. Am. J. Respir. Crit. Care Med. 153: 997-1004 [Abstract].
8. Alberti, A., F. Gallo, A. Fongaro, S. Valenti, and A. Rossi. 1995. P0.1 is a useful parameter in setting the level of pressure support ventilation. Intens. Care Med. 21: 547-553 [Medline].
9. Mancebo, J., P. Albaladejo, E. Bak, S. Elatrous, D. Touchard, M. Subirana, F. Lemaire, A. Harf, and L. Brochard. 1996. Use of the occlusion pressure (P0.1) to titrate the level of external PEEP in patients with dynamic hyperinflation (abstract). Am. J. Respir. Crit. Care Med. 153: A368 .
10. Whitelaw, W. A., J. P. Derenne, and J. Milic-Emili. 1975. Occlusion pressure as a measure of respiratory center output in conscious man. Respir. Physiol. 23: 181-199 [Medline].
11. Fernandez, R., S. Benito, J. Sanchis, J. Milic, Emili, and A. Net. 1988. Inspiratory effort and occlusion pressure in triggered mechanical ventilation. Intens. Care Med. 14: 650-653 [Medline].
12. Conti, G., G. Cinnella, E. Barboni, F. Lemaire, A. Harf, and L. Brochard. 1996. Estimation of occlusion pressure during assisted ventilation in patients with intrinsic PEEP. Am. J. Respir. Crit. Care Med. 154: 907-912 [Abstract].
13. Conti, G., R. A. De Blasi, P. Pelaia, S. Benito, M. Rocco, M. Antonelli, M. Bufi, C. Mattia, and A. Gasparetto. 1992. Early prediction of successful weaning during pressure support ventilation (PSV) weaning in chronic obstructive pulmonary disease (COPD) patients. Crit. Care Med. 20: 366-371 [Medline].
14. Tobin, M. J., W. Perez, S. H. Guenther, B. J. Semmes, M. J. Mador, S. J. Allen, R. F. Lodato, and D. R. Dantzker. 1986. The pattern of breathing during successful and unsuccessful trials of weaning from mechanical ventilation. Am. J. Respir. Crit. Care Med. 134: 1111-1118 .
15.
Laghi, F.,
N. D'Alfonso, and
M. J. Tobin.
1995.
Pattern of recovery from
diaphragmatic fatigue over 24 hours.
J. Appl. Physiol.
79:
539-546
16. Iotti, G. A., J. X. Brunner, A. Braschi, T. Laubscher, M. C. Olivei, A. Palo, C. Galbusera, and A. Comelli. 1996. Closed-loop control of airway occlusion pressure at 0.1 second (P. 01) applied to pressure-support ventilation: algorithm and application in intubated patients. Crit. Care Med. 24: 771-779 [Medline].
17. Sassoon, C. S. H., T. T. Te, C. K. Mahutte, and R. W. Light. 1987. Airway occlusion pressure: an important indicator for successful weaning in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 135: 107-113 [Medline].
18.
Sassoon, C. S. H.,
C. K. Mahutte,
T. T. Te,
D. H. Simmons, and
R. W. Light.
1988.
Work of breathing and airway occlusion pressure during
assist-mode mechanical ventilation.
Chest
93:
571-576
19. Montgomery, A., R. H. O. Holle, S. R. Neagley, D. J. Pierson, and R. B. Schroene. 1987. Prediction of successful ventilator weaning using airway occlusion pressure and hypercapnic challenge. Chest 91: 996-999 .
20. Fernandez, R., J. Cabrera, N. Calaf, and S. Benito. 1990. P0.1/PIMax: an index for assessing respiratory capacity in acute respiratory failure. Intens. Care Med. 16: 175-179 [Medline].
21. Miksch, S., W. Horn, C. Popow, and F. Paky. 1997. Utilizing temporal data abstraction for data validation and therapy planning for artificially ventilated newborn infants. Artif. Intell. Med. 8: 543-576 .
22. Larsson, J. E., B. Hayes-Roth, D. M. Gaba, and B. E. Smith. 1997. Evaluation of a medical diagnosis system using simulator test scenarios. Artif. Intell. Med. 11: 119-140 [Medline].
23. Rutledge, G. W., G. E. Thomsen, B. R. Farr, M. A. Tovar, J. X. Polaschek, I. A. Beinlich, L. B. Sheiner, and L. M. Fagan. 1993. The design and implementation of a ventilator-management advisor. Artif. Intell. Med. 5: 67-82 [Medline].
24. Chambrin, M.-C., C. Chopin, and K. H. Mangalaboyi. 1992. Autoregulated inspiratory support system. 14th IEEE Engineering in Medicine and Biology Annual International Conference. Institute of Electrical and Electronics Engineers, Piscataway, NJ. 2419-2420.
25. Laubscher, T. P., W. Heinrichs, N. Weiler, G. Hartmann, and J. X. Brunner. 1994. An adaptive lung ventilation controller. IEEE Trans. Biomed. Eng. 41: 51-58 [Medline].
26.
Strickland, J. H., and
J. H. Hasson.
1991.
A computer-controlled ventilator weaning system: a clinical trial.
Chest
100:
1096-1099
27.
Strickland, J. H., and
J. H. Hasson.
1993.
A computer-controlled ventilator weaning system: a clinical trial.
Chest
103:
1220-1226
28. Le Gall, J. R., P. Loirat, A. Alperovitch, P. Glaser, C. Granthil, D. Mathieu, P. Mercier, R. Thomas, and D. Villers. 1984. A simplified acute physiology score for ICU patients. Crit. Care Med. 12: 975-977 [Medline].
This article has been cited by other articles:
![]() |
N. MacIntyre Discontinuing Mechanical Ventilatory Support Chest, September 1, 2007; 132(3): 1049 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-M. Boles, J. Bion, A. Connors, M. Herridge, B. Marsh, C. Melot, R. Pearl, H. Silverman, M. Stanchina, A. Vieillard-Baron, et al. Weaning from mechanical ventilation Eur. Respir. J., May 1, 2007; 29(5): 1033 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K Vawdrey, R. M Gardner, R. Evans, J. F Orme Jr, T. P Clemmer, L. Greenway, and F. A Drews Assessing Data Quality in Manual Entry of Ventilator Settings JAMIA, May 1, 2007; 14(3): 295 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lellouche, J. Mancebo, P. Jolliet, J. Roeseler, F. Schortgen, M. Dojat, B. Cabello, L. Bouadma, P. Rodriguez, S. Maggiore, et al. A Multicenter Randomized Trial of Computer-driven Protocolized Weaning from Mechanical Ventilation Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 894 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garland Improving the ICU: Part 2 Chest, June 1, 2005; 127(6): 2165 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Spahija, J. Beck, M. de Marchie, A. Comtois, and C. Sinderby Closed-Loop Control of Respiratory Drive Using Pressure-Support Ventilation: Target Drive Ventilation Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1009 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vitacca, L. Bianchi, E. Zanotti, A. Vianello, L. Barbano, R. Porta, and E. Clini Assessment of Physiologic Variables and Subjective Comfort Under Different Levels of Pressure Support Ventilation Chest, September 1, 2004; 126(3): 851 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Petter, R. L. Chiolero, T. Cassina, P.-G. Chassot, X. M. Muller, and J.-P. Revelly Automatic "Respirator/Weaning" with Adaptive Support Ventilation: The Effect on Duration of Endotracheal Intubation and Patient Management Anesth. Analg., December 1, 2003; 97(6): 1743 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. MacIntyre Evidence-Based Guidelines for Weaning and Discontinuing Ventilatory Support : A Collective Task Force Facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine Chest, December 1, 2001; 120 (2009): 375S - 396S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Ely, M. O. Meade, E. F. Haponik, M. H. Kollef, D. J. Cook, G. H. Guyatt, and J. K. Stoller Mechanical Ventilator Weaning Protocols Driven by Nonphysician Health-Care Professionals : Evidence-Based Clinical Practice Guidelines Chest, December 1, 2001; 120 (2009): 454S - 463S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Critical Care Medicine in AJRCCM 2000 Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1347 - 1361. [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Ventilator Monitoring, and Sharing the Data with Patients Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 810 - 811. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |